Zymeworks (ZYME) Accounts Payables (2021 - 2026)

Zymeworks (ZYME) has 6 years of Accounts Payables data on file, last reported at $30.2 million in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables fell 20.92% year-over-year to $30.2 million; the trailing twelve-month figure through Mar 2026 stood at $30.2 million (down 20.92% YoY), and the FY2025 full-year result was $36.3 million, down 39.26% from the prior year.
• Accounts Payables retreated to $30.2 million in Q1 2026, from $36.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $87.5 million in Q4 2022 to a low of $30.2 million in Q1 2026.
• A 5-year average of $50.4 million and a median of $47.4 million in 2024 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 39.3% in 2022 and plunged 47.42% in 2023, its largest moves.
• Tracing ZYME's Accounts Payables over 5 years: stood at $87.5 million in 2022, then tumbled by 47.42% to $46.0 million in 2023, then jumped by 30.11% to $59.8 million in 2024, then slumped by 39.26% to $36.3 million in 2025, then dropped by 16.84% to $30.2 million in 2026.
• Business Quant data shows ZYME's Accounts Payables at $30.2 million in Q1 2026, $36.3 million in Q4 2025, and $34.4 million in Q3 2025.